Article révisé par les pairs
Titre:
  • Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study.
Auteur:Raoul, Jean-Luc; Van Laethem, Jean-Luc; Peeters, Marc; Brezault, Catherine; Husseini, Fares; Cals, Laurent; Nippgen, Johannes; Loos, Anja-Helena; Rougier, Philippe
Informations sur la publication:BMC cancer, 9, page (112)
Statut de publication:Publié, 2009
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Aged
Antibodies, Monoclonal -- administration & dosage -- adverse effects
Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use
Camptothecin -- administration & dosage -- adverse effects -- analogs & derivatives
Colorectal Neoplasms -- drug therapy -- pathology
Diarrhea -- chemically induced
Disease Progression
Dose-Response Relationship, Drug
Drug Administration Schedule
Exanthema -- chemically induced
Female
Fluorouracil -- administration & dosage -- adverse effects
Follow-Up Studies
Humans
Infusions, Intravenous
Leucovorin -- administration & dosage -- adverse effects
Leukopenia -- chemically induced
Male
Middle Aged
Neoplasm Metastasis
Survival Analysis
Treatment Outcome
Vomiting -- chemically induced
Note générale:Clinical Trial, Phase I
Clinical Trial, Phase II
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:1471-2407
info:doi/10.1186/1471-2407-9-112
info:pii/1471-2407-9-112
info:scp/65649086838
info:pmid/19366444
PMC2678147

Documents en relation

DI-fusion